Title of article
Identification of Three Novel Mutations in the FANCA, FANCC, and ITGA2B Genes by Whole Exome Sequencing
Author/Authors
Negahdari, Samira Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Zamani, Mina Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Seifi, Tahereh Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Sedighzadeh, Sahar Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Mazaheri, Neda Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Zeighami, Jawaher Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Sedaghat, Alireza Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Saberi, Alihossein Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Hamid, Mohammad Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , keikhaei, Bijan Health Research Institute - Research Centre of Thalassemia and Hemoglobinopathies - Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran , Radpour, Ramin Tumor Immunology - Department for BioMedical Research (DBMR) - University of Bern, Bern, Switzerland , Shariati, Gholamreza Narges Genetics Diagnostic Laboratory, Ahvaz, Iran , Galehdari, Hamid Health Research Institute - Research Centre of Thalassemia and Hemoglobinopathies - Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Pages
7
From page
1
To page
7
Abstract
Background: Various blood diseases are caused by mutations in the FANCA, FANCC, and ITGA2B
genes. Exome sequencing is a suitable method for identifying single‑gene disease and genetic
heterogeneity complaints. Methods: Among families who were referred to Narges Genetic and PND
Laboratory in 2015‑2017, five families with a history of blood diseases were analyzed using the
whole exome sequencing (WES) method. Results: We detected two novel mutations (c.190‑2A>G
and c.2840C>G) in the FANCA gene, c. 1429dupA mutation in the FANCC gene, and c.1392A>G
mutation in the ITGA2B gene. The prediction of variant pathogenicity has been done using
bioinformatics tools such as Mutation taster PhD‑SNP and polyphen2 and were confirmed by Sanger
sequencing. Conclusions: WES could be as a precise tool for identifying the pathologic variants
in affected patient and heterozygous carriers among families. This highly successful technique will
remain at the forefront of platelet and blood genomic research.
Keywords
sequence analysis , Fanconi anemia , DNA , congenital abnormalities , Blood platelets
Journal title
International Journal of Preventive Medicine (IJPM)
Serial Year
2020
Record number
2610460
Link To Document